Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey

We investigated menstrual irregularities after the first and second doses of the COVID-19 vaccine. Women answered a customised online questionnaire (ClinicalTrial.gov ID: NCT05083065) aimed to assess the vaccine type, the phase of the menstrual cycle during which the vaccine was administered, the occurrence of menstrual irregularities after the first and second doses, and how long …

Continue reading Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey

COVID-19 vaccination and menstrual cycle changes: A United Kingdom (UK) retrospective case-control study

There has been increasing public concern that COVID-19 vaccines cause menstrual cycle disturbances, yet there is currently limited data to evaluate the impact of vaccination on menstrual health. Our objectives were (1) to evaluate the prevalence of menstrual changes following vaccination against COVID-19, (2) to test potential risk factors for any such changes, and (3) …

Continue reading COVID-19 vaccination and menstrual cycle changes: A United Kingdom (UK) retrospective case-control study

Association between #obesity with pattern and length of #menstrual cycle: The role of metabolic and hormonal markers

To evaluate in a sample of Chilean adult women, the association between adiposity markers with pattern and length of the menstrual cycle, assessing the influence of metabolic markers and hormones in this relationship. Study design We conducted a cross-sectional study involving 401 premenopausal women belonging to the DERCAM study (Determinants of Breast Cancer Risk) from …

Continue reading Association between #obesity with pattern and length of #menstrual cycle: The role of metabolic and hormonal markers

Age at #period cessation and trajectories of #cardiovascular risk factors across mid and later life

To examine the association between age at period cessation and trajectories of anthropometry, blood pressure, lipids and glycated haemoglobin (HbA1c) from midlife to age 69 years.. ..We found no evidence that age at period cessation was associated with trajectories of log triglyceride, LDL-C and HDL-C from 53 to 69 years and trajectories of SBP or …

Continue reading Age at #period cessation and trajectories of #cardiovascular risk factors across mid and later life